Skip to main content
Premium Trial:

Request an Annual Quote

Life Tech Inks Supply Deal with Novartis for Dynabeads

NEW YORK (GenomeWeb News) – Life Technologies today said that it has signed an agreement to supply Novartis with its Dynabeads for use in immunotherapeutics being developed by the drug firm for cancer.

The agreement includes a license to Life Tech's intellectual property to perform the resulting therapy and it is exclusive for use in the field of chimeric antigen receptors for the treatment of cancer. Financial and other terms of the agreement were not disclosed.

Novartis is developing personalized immunotherapeutics, whereby blood cells are removed from a cancer patient. Then, the T cells are isolated and activated, they are genetically modified so the cells recognize and attack cancer cells, the T cells are expanded, and then re-introduced into the patient.

Under the terms of the deal, the Dynabeads will be used by Novartis to isolate, activate, and expand the T cells.

"The collaboration with Novartis highlights the distinct capabilities that Life Technologies can provide in the therapeutic realm," Life Tech Chairman and CEO Greg Lucier said in a statement. "Taken with our previous announcements of companion diagnostic collaborations, the current agreement demonstrates how Life is uniquely positioned to facilitate drug development through alliances with pharma."

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.